Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Hysteroscopic Morcellator Versus the Bipolar Resectoscope for Removal of Lager Intrauterine Polyps, Removal of Submucous Myomas and Removal of Residual Placental Tissue: a Randomized Controlled Trial.

NCT01537822 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT01537822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01537822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Hysteroscopic Morcellator Versus the Bipolar Resectoscope for Removal of Lager Intrauterine Polyps, Removal of Submucous Myomas and Removal of Residual Placental Tissue: a Randomized Controlled Trial.
Lead sponsor
University Hospital, Ghent
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2011
Completion date
July 1, 2018
Enrollment
253 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

large intrauterine polyps, residual placental tissue, smaller type 0 and 1 myomas